Temasek to invest in Shanghai Pharma's IPO

Reuters, 3 May 2011
Temasek Holdings TEM.UL is expected to invest $300 million, Malaysian conglomerate Guoco Group Ltd (0053.HK) plans to spend $150 million, while Pfizer Inc (PFE.N) and Bank of China Group Investment each plan to invest $50 million in the IPO, the newspaper reported, citing a person familiar with the matter.
The shares will be sold to the cornerstone investors at HK21.80 to HK$26 apiece, with a one-year lock-up period, the paper added. Full story

Related:
Shanghai Pharma Share Sale to Raise $2.2 Billion as Temasek, Pfizer Invest - Bloomberg